Gaudium Ivf & Women Health Ltd. · NSE:GAUDIUMIVF
Gaudium Ivf & Women Health — Q1 FY27 Earnings Presentation
36 slides from Gaudium Ivf & Women Health's earnings presentation, Aug 14, 2026
Slide 1: Delivering Motherhood Dreams
gaudium |VF Delivering Motherhood Dreams August 14, 2026 BSE Limited National Stock Exchange of India Limited s, Dalal Exchange Plaza, C-1,-1, Bl Block G. 3 i j bhoy T gl;;;gtz eFJOer?ee o o Bandra Kurla Complex, Bandra (E), 400051, Maharashtra Mumbaii — 400051, Mumbaii — 400001, Maharashtra Scrip C
Slide 2: Investor Presentation Q1 FY27
GAUDIUM IVF and WOMEN HEALTH LTD. INVESTOR PRESENTATION Q1 FY27
Slide 3: Safe Harbour
Safe Harbour This document is prepared only for information purpose and do not solicit/recommend/guide for any Investment/Buy-Sell in any financial instrument of Gaudium IVF and Women Health Limited (“Gaudium”) and/or any of its subsidiary company or associate company. Neither Gaudium nor any of its
Slide 4: Table of Contents
Table of Contents 01 02 03 04 Company at a Glance IVF Industry Overview Center/Hub Wise Details Financial Snapshot Shareholding Pattern & Key Market Data Journey of Gaudium IVF Growth Drivers in the AI That Makes the Q1 FY27 Standalone P&L Industry Difference Case Studies Proce
Slide 5: About Us
ABOUT US
Slide 6: Company at a Glance
Company at a Glance Founded: March 2015 by Dr Manika Khanna and Dr. Peeyush Khanna Network: 8 Hubs + 28 Spokes | Presence: 9 States across India Services Revenue Split AI Initiatives to help improve success rate: 29.41% SiD & ERICA 4.35% Success Rates: Success Rates: First Attempt - 62% Multiple Att
Slide 7: Journey of Gaudium IVF
Journey of Gaudium IVF 2009 2016 2017 2019 Janakpuri Greater Ludhiana Patna Hub Hub Kailash Hub Hub Spokes at Bihar, Srinagar & Punjab 2026 2024 2023 2022 BSE & NSE Listing Srinagar Hub Bangalore Hub Mumbai Hub South Delhi Hub Spokes at Mumbai Gurgaon & Nagpur (Under construction Stage) 6
Slide 8: Process Flow - IVF Treatment
Process Flow - IVF Treatment A seamless, patient-centric journey supported by clinical excellence and care at every step 1 Conversion of Lead 2 IVF Process Starts 3 Hospital & Post Care Injections Success / Lead Generated Package amount either Failure of ET & Follow up paid in full or in installment
Slide 9: AI-Powered End-to-End Fertility Solutions
AI-Powered End-to-End Fertility Solutions Advanced IVF Male Infertility Ovulation Induction Egg Freezing ERICA SiD Treatment Infertility Surgeries Frozen Embryo Embryo Freezing Gynae Laparoscopy for PCOD/PCOS Transfer Consultation Infertility 8
Slide 10: Key Clinical Highlights
Key Clinical Highlights SOP-Driven Organization AI-Powered IVF In-House Trained Talent From clinical, embryology and doctors to First in India, 2nd outside the US to Clinicians and embryologists trained within housekeeping. introduce AI tools SID & ERICA. Gaudium. Constant Innovation Signature Labs
Slide 11: Strategic Milestones
Strategic Milestones India's First India's No. 1 IVF company to be listed on the stock IVF Clinic ranking as per the Health Survey market, marking a historic milestone in the conducted by Times of India. fertility care industry. India's First India's First IVF chain to introduce Artificial Intellige
Slide 12: Business Overview
BUSINESS OVERVIEW
Slide 13: IVF Industry Overview
IVF Industry Overview Strong demographic tailwinds, significant treatment gap and evolving industry structure create a long runway for scalable growth MARKET SIZE & GROWTH SIGNIFICANT UNDERPENETRATION STRUCTURAL SUPPLY GAP India IVF Market Size (USD Billion) Huge gap between need and treatment IVF a
Slide 14: Growth Drivers in the Industry
Growth Drivers in the Industry IMPROVING DECLINING DELAYED LIFESTYLE & AWARENESS & TECHNOLOGY- MEDICAL TOURISM REGULATORY FERTILITY RATES PARENTHOOD HEALTH FACTORS ACCEPTANCE DRIVEN OUTCOMES ADVANTAGE TAILWIND • India’s fertility rate • Rising age at • Rising incidence of • Growing awareness • Advan
Slide 15: Entry Barriers in Industry
Entry Barriers in Industry Regulatory High Capital & Brand Trust Technology and Compliance Infrastructure Costs and Reputation R&D Dependence Ethical and Social Requirement of Market Sensitivities Skilled Manpower Consolidation Navigating Key Industry Barriers Built a Scalable Fertility Platform Eve
Slide 16: Our Moat, Our Momentum
Our Moat, Our Momentum Eleven strengths built over 15+ years that create a compounding advantage for Gaudium IVF SOP-Driven Pan-India Operations Presence Established & Trusted Brand Global Reach Clinical Excellence Emotional Counselling Support Strong Clinical Leadership Multi-Channel Innovation - P
Slide 17: Pan-India Presence
Pan-India Presence 1 2 Jammu & Kashmir 1 3 Punjab 3 2 2 Delhi / NCR Haryana 1 Uttar Pradesh 1 6 Bihar 1 6 Maharashtra 1 5 Karnataka 1 8 Hubs 28 Spokes Comprehensive Extending access to Tamil Nadu Care & Specialists Quality fertility care 16
Slide 18: Serving Patients Around The Globe
Serving Patients Around The Globe Delivering world – class fertility care to patients across the globe Canada UK Middle East Indonesia India Africa New Zealand Australia 17
Slide 19: AI That Makes the Difference
AI That Makes the Difference Gaudium is among the few IVF providers in India to deploy both SiD and ERICA, creating an integrated AI-assisted clinical workflow that supports improved outcomes and consistent success across centres. SiD Selecting the best sperm for fertilisation (ICSI) ERiCA ERICA AI
Slide 20: Infrastructure & Facilities at Centers
Infrastructure & Facilities at Centers Clinical Facilities Specialized Equipment’s • Consultation rooms for patient and doctor • Incubators to help embryos grow and engagement for preliminary examination develop properly during the IVF process • Advanced andrology lab equipped for • Laminar flow hoo
Slide 21: 360° Customer Acquisition
360° Customer Acquisition • Reach Intent-Based Audience • Outreach in Tier II and Tier III cities • Historically strong Patient Network • Aggressive social media marketing • Well-established Doctor network • CXO Branding to build Dr. Manika as Brand Ambassador Digital Word of Marketing Mouth • Perf
Slide 22: Rapid Growth Strategy
Rapid Growth Strategy FY27 2 out of 10 1 In Delhi/NCR 1 In Nagpur Hubs Launching Soon FY28 8 new centers FY29 1 new center The addition of new centers will enhance Gaudium IVF’s pan-India brand visibility Increased customer footfall is expected to drive higher revenues and strengthen key financial p
Slide 23: Board Of Directors
Board Of Directors Holds an MBBS (Gold Medallist) and MD in Obstetrics & Gynecology from Maharaja Sayajirao University of Baroda. She has completed training in Advanced Gynecological Endoscopic Surgery in Kiel, Germany, and in advanced gynecological endoscopy from Melbourne IVF Gujarat Private Limit
Slide 24: Q1 FY27 Financial Performance
Q1 FY27 FINANCIAL PERFORMANCE
Slide 25: Financial Snapshot
Financial Snapshot Revenue From Operations (Rs. Lakhs) Operating EBITDA (Rs. in Lakhs) 1,937.66 515.28 1,775.59 242.40 Q1 FY26 Q1 FY27 Q1 FY26 Q1 FY27 PAT (Rs. in Lakhs) PAT Margin 307.62 17.33% 177.59 9.17% Q1 FY26 Q1 FY27 Q1 FY26 Q1 FY27 *Note: Margin Ratios are based on PAT from Continuing Operat
Slide 26: Financial Statement (Rs. Lakhs) Standalone
Financial Statement (Rs. Lakhs) Standalone Income statement Q1 FY27 Q1 FY26 YOY Q4 FY26 QOQ FY26 Revenue from Operations 1367.73 1227.32 11.44% 2,216.60 -38.30% 7,157.85 EBITDA (Ex. Other Income) 217.40 415.55 -47.68% 1,126.15 -80.70% 3,456.59 EBITDA Margins % 15.89% 33.86% -1797 bps 50.81% -3492 bp
Slide 27: Financial Statement (Rs. Lakhs) Consolidated
Financial Statement (Rs. Lakhs) Consolidated Income statement Q1 FY27 Q1 FY26 YOY Q4 FY26 QOQ FY26 Revenue from Operations 1937.66 1775.59 9.13% 3,035.11 -36.16% 10,435.70 EBITDA (Ex. Other Income) 242.40 515.28 -52.96% 1,217.20 -80.09% 3,770.39 EBITDA Margins % 12.51% 29.02% -1651 bps 40.10% -2759
Slide 28: Annexures
ANNEXURES
Slide 29: Shareholding Pattern & Key Market Data
Shareholding Pattern & Key Market Data Additional Slide Proposed Shareholding Pattern Key Market Data 23% BSE Ticker 544709 NSE Symbol GAUDIUMIVF 3% No. of Shares Outstanding* 7,27,86,884 Share Price** Rs 112.95 2% Market Capitalisation (Rs. Cr) Rs 822.13 71% Industry Healthcare Service Provider Pro
Slide 30: Case Studies - Our Amazing Successes
Case Studies - Our Amazing Successes ● 2009 – A Historic First: 51-year-old ● IVIG Therapy Breakthrough: 8 prior losses; achieved a successful IVF & live birth with first live birth through innovative IVIG her own eggs. therapy. ● 2012 – 15 Failed IVFs: 15 prior failures (5 ● NRI Couple – 12 Failure
Slide 31: Most Awarded IVF Chain in India
Most Awarded IVF Chain in India India best Pracice Award: IVF Former President of India India best Pracice Award: IVF India’s Most Powerful Symbol of IVF Leader of the Year, India Smt. Praibha Pail for her brand Excellence by Power Chain of the Year 2019 by 2023 Award by Gurudev outstanding work in
Slide 32: Additional Recognition Over the Years
Additional Recognition Over the Years 2021 2017 2017 Oxford Academy, UK Times Healthcare Achievers BusinessWorld Awards Name in Medical Science — Global Women's Rising Stars O&G — Best Speciality Centre Healthcare Personality of the Year – Women Health 2016 2016 2016 Indian Medical Association URS A
Slide 33: CSR Initiative
CSR Initiative Ladli Shiksha & Swasthya Initiative Empowering adolescent girls from underserved communities through education access, health literacy and life-skills development - helping build informed choices, stronger confidence and resilient futures. EWS & Marginalized 2,500+ 4 Govt. Schools 11–
Slide 34: Patient Testimonials
Delivering Matherisoe Dreams rf gaudium IVF Patient Testimonials isgll 2 Deus crretne nin 33
Slide 35: Slide 35
Slide 36: Thank You!
THANK YOU ! For further queries, Please contact: Rakesh Kumar Sharma (CFO) cmd@gaudiumivfcentre.com For further queries, Please contact: Rushabh Shah Anand Venugopal Naomi Fernandes rushabh.shah@adfactorspr.co anand.venugopal@adfactorspr.co naomi.fernandes@adfactorspr.com m m M: +91 70452 60278 M: +
Gaudium IVF and Women Health — Q1 FY27 Earnings Presentation on 6ix